deltatrials
Unknown PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT02000362

Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD)

An Open-labelled, Multi Center, Comparative Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease

Sponsor: Kang Stem Biotech Co., Ltd.

Conditions Crohn's Disease
Interventions Stem cells
Updated 8 times since 2017 Last updated: Sep 5, 2017 Started: Aug 31, 2014 Primary completion: Sep 30, 2018 Completion: Oct 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Crohn's Disease, this trial is ongoing. The trial is conducted by Kang Stem Biotech Co., Ltd. and has accumulated 8 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Oct 2017 · 9 months · monthly snapshotRecruiting~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotRecruiting~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshotRecruiting~Nov 2018 – ~Jan 2021 · 26 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE1/PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1/PHASE2

    Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE1_PHASE2

  5. Nov 2018 — Jan 2021 [monthly]

    Unknown Status PHASE1_PHASE2

    Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

  1. Jun 2018 — Nov 2018 [monthly]

    Recruiting PHASE1_PHASE2

  2. Oct 2017 — Jun 2018 [monthly]

    Recruiting PHASE1_PHASE2

  3. Jan 2017 — Oct 2017 [monthly]

    Recruiting PHASE1_PHASE2

    First recorded

Aug 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Kang Stem Biotech Co., Ltd.
Data source: Kang Stem Biotech Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations